Center for Hematologic Malignancies, MSKCC
United States of America (USA)
1 October 2018 - 30 September 2019
Principal institution: Memorial Sloan Kettering Cancer Center (MSKCC)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Center for Hematologic Malignancies, MSKCC published between 1 October 2018 - 30 September 2019 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 5 | 0.38 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 5 | 0.38 | |
Top articles by Altmetric score in current window
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Nature Medicine
2018-12-06
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML
Journal of Experimental Medicine
2019-04-01
Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
Nature Communications
2019-06-19
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
Science Translational Medicine
2019-09-04
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
